KOREA WHO
-
-
-
CEO and CTO of Biosolution
Lee Jung-sun
Contributed to Cartilage Cell Therapy, Leading Organoid Business
-
Last Updated on Oct 20, 2025
-
CEO and CTO of Biosolution
Life Summary
Lee Jung-sun is the President and Chief Technology Officer (CTO) of Biosolution. He also serves as President and CTO of Helixmith.
He was born on June 24, 1972.
He earned his bachelor’s degree in veterinary medicine from Konkuk University, and later obtained both his master’s and doctoral degrees in veterinary medicine from the same university.
Lee joined MCTT, the predecessor of Biosolution, where he served as Head of the Research Laboratory before taking charge of overall research management.
He was appointed CEO in 2016, stepped down later, and returned in 2024 as both CEO and CTO.
He contributed to the commercialization of “CartiLife,” an autologous chondrocyte therapy developed in-house.
Focusing on new growth businesses, he has been leading the development of organoid products based on human tissue model technology and expanding into the preclinical CRO (Contract Research Organization) business.
#Biosolution #LeeJungsun #Helixmith #biotechnology #CRO #CartiLife #organoid #regenerativemedicine #veterinaryscience #celltherapy
He was born on June 24, 1972.
He earned his bachelor’s degree in veterinary medicine from Konkuk University, and later obtained both his master’s and doctoral degrees in veterinary medicine from the same university.
Lee joined MCTT, the predecessor of Biosolution, where he served as Head of the Research Laboratory before taking charge of overall research management.
He was appointed CEO in 2016, stepped down later, and returned in 2024 as both CEO and CTO.
He contributed to the commercialization of “CartiLife,” an autologous chondrocyte therapy developed in-house.
Focusing on new growth businesses, he has been leading the development of organoid products based on human tissue model technology and expanding into the preclinical CRO (Contract Research Organization) business.
#Biosolution #LeeJungsun #Helixmith #biotechnology #CRO #CartiLife #organoid #regenerativemedicine #veterinaryscience #celltherapy